Pancreatic Cancer Research

ResearcherWuxi People's HospitalNo recent work listed

Fangmei An

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6116-1989; OpenAlex author ID A5046486654. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 4

  1. Dishevelled-Associated Activator of Morphogenesis 2 (DAAM2) Predicts the Immuno-Hot Phenotype in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fmolb.2022.750083↗
  2. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways. Co-author DOI 10.3892/ol.2020.12021↗
  3. PSMC2 is Up-regulated in Pancreatic Cancer and Promotes Cancer Cell Proliferation and Inhibits Apoptosis. Co-author DOI 10.7150/jca.27616↗
  4. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer. Last author DOI 10.3892/or.2017.5919↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junli Ding · 3 shared papers, 2017–2020 · strength 0.31
  2. Dayang Chen · 2 shared papers, 2017–2020 · strength 0.19
  3. Qiang Zhan · 2 shared papers, 2017–2020 · strength 0.19
  4. Qiang Zhan · 1 shared paper, 2022 · strength 0.19
  5. Qinglin Zhang · 1 shared paper, 2022 · strength 0.19
  6. Wei Huang · 1 shared paper, 2019 · strength 0.12
  7. Jing Qin · 1 shared paper, 2019 · strength 0.12
  8. Yunan Zhang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.